Even though the production was stopped, the company will continue to monitor vaccinated volunteers in the C. diff trialand report any findings to the medical community.
This is the latest setback to Sanofi’s vaccine program. On Wednesday the company said use of its new dengue vaccine may be limited after evidence revealed the vaccine could worsen the disease in people who have not been previously exposed to the virus.
More articles on supply chain:
FDA: Biotin supplements may interfere with lab tests
Gilead launches hepatitis drug in China at one-fifth the US price
CVS launches ‘real-time benefits’ tool to increase price transparency
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
